Blog
0
Perjeta Plus Herceptin Without Chemo Sufficient for HER2+ Metastatic Breast Cancer
0

Certain patients with metastatic breast cancer may not need chemotherapy, and can be treated with Perject plus Herceptin. The treatment combination of ...

0
After More Than a Decade with CLL, MRD Results Left Patient ‘Over the Moon’
0

Chronic lymphocytic leukemia (CLL) has been part of Geoff Grubbs’ life for nearly 15 years. But recently, after five lines of treatment and participation in ...

0
Sugar and cancer – what you need to know
0

This post was first published in 2017 and was most recently reviewed and updated in August 2023. There’s a lot of information online about sugar and ...

0
Patients With Lung Cancer Respond to ‘Did You Smoke?’
0

The Living!!! With Lung Cancer Support Group meets virtually twice per month and is moderated by University of Kansas Cancer Center social worker Sarah ...

0
Exercise May Improve Sexual Dysfunction in Men With Prostate Cancer
0

Aerobic or resistance exercise improved sexual dysfunction in men with prostate cancer, recent research showed. Men with prostate cancer who performed ...

0
Opening Doors for Precision Medicine in Breast Cancer
0

Your browser does not support the audio element.Listen to, "Opening Doors for Precision Medicine in Breast Cancer." Veliparib, a poly (ADP-ribose) ...

0
Lighting the World with Greenlights, One Bracelet at a Time
0

A year ago, I attended a cancer camp called Camp Make-a-Dream, and I found a specific calling: creativity in jewelry. At this camp, I attended a workshop to ...

0
Social Connectedness May Improve Wellbeing in Young Cancer Survivors
0

Social isolation is an issue for many young cancer survivors, and it may have an impact on their overall wellbeing. Increased levels of social isolation are ...

0
FDA Approves Hepzato Kit for Metastatic Uveal Melanoma
0

The Food and Drug Administration (FDA) approved the Hepzato Kit (melphalan/hepatic delivery system) for the treatment of patients with metastatic uveal ...

0
FDA Approves Elrexfio for Heavily Pretreated Relapsed/Refractory Multiple Myeloma
0

The Food and Drug Administration (FDA) approved Elrexfio (elranatamab-bcmm) to treat adults with relapsed or refractory multiple myeloma who previously ...

0
Cancer by the Numbers
0

I like routine. I wake up around the same time every day, watch and read quick snippets of the morning news, and determine what kind of exercise I’m going ...

0
Immunotherapy Shows Promise in Penile Cancer Subset
0

Immunotherapy showed promise in certain patients with metastatic or locally advanced penile cancer. Immune checkpoint inhibitors may be a promising option ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart